QAdvis News #2 – 2022
Artificial Intelligence / Machine Learning – and one of our consultants Cilla Lundevall. It is ...
Author Aurevia:
QAdvis participate in Regulatory Summit 31, March
Meet our new CEO Emma Axelsson and listen to three of our consultants Cecilia Emanuelsson, Nils ...
Post-market clinical follow-up under MDR
Post-market clinical follow-up (PMCF) is an important requirement under the EU Medical Device ...
QAdvis News #1 – 2022
2022 has just started! We have several exciting news to share with you! 2022 has just started and ...
Publication of Regulation (EU) 2022/112
–A Risk based roll-out plan for certain In Vitro Diagnostic medical devices and In-house devices On ...
Clinical Trials Regulation (CTR) (Regulation EU No 536/2014)
The Clinical Trials Regulation (CTR; EU No 536/2014) will replace the EU Clinical Trial Directive ...
Welcome to QAdvis!
We are very pleased to welcome a new consultant, Nils Lidström to our QAdvis team! Nils has a ...
Initiative for Accelerating Clinical Trials in the EU (ACT EU)
The European Commission (EC), Heads of Medicines Agencies (HMA) and the European Medicines Agency ...
We wish all our customers and partners a Merry Christmas and a Happy New Year!
Every day a child is diagnosed with cancer. But there is hope. More children than ever survive ...